WCM Investment Management »

Halozyme Therapeutics shares owned by WCM Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by WCM Investment Management from 13F filings

Historical chart of WCM Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by WCM Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by WCM Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 306k 40.68
2023-12-31 $12M 317k 37.15
2023-09-30 $11M 292k 38.20
2023-06-30 $8.6M 236k 36.55
2023-03-31 $8.4M 220k 38.19
2021-09-30 $5.5M 136k 40.68
2021-06-30 $6.1M 135k 45.41
2021-03-31 $5.4M 130k 41.69
2020-12-31 $5.7M 133k 42.71
2020-09-30 $3.5M 132k 26.28
2020-06-30 $5.5M 204k 26.81
2020-03-31 $3.5M 194k 17.99
2019-12-31 $2.4M 137k 17.73
2019-09-30 $489k 32k 15.52
2019-06-30 $541k 32k 17.17
2019-03-31 $515k 32k 16.10